Resultados de procura - Michèle Cavo

Limitar resultados
  1. 1
    Imaging in multiple myeloma: How? When?

    Imaging in multiple myeloma: How? When? por Elena Zamagni, Paola Tacchetti, Michèle Cavo

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update

    Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update por Luana Bavaro, Maurizio Martelli, Michèle Cavo, Simona Soverini

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Staging of chronic lymphocytic leukemia

    Staging of chronic lymphocytic leukemia por Michele Baccarani, Michèle Cavo, Marco Gobbi, F. Lauria, S Tura

    Publicado 1982
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

    Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy por Simona Soverini, Manuela Mancini, Luana Bavaro, Michèle Cavo, Giovanni Martinelli

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years

    Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years por Francesca Palandri, Nicola Polverelli, Daria Sollazzo, Marco Romano, Lucia Catani, Michèle Cavo, Nicola Vianelli

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    PGE<sub>2</sub>-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an<i>In Vitro</i>Antileukemic Immune Response

    PGE<sub>2</sub>-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit an<i>In Vitro</i>Antileukemic Immune Response por Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michèle Cavo, Darina Očadlíková, Roberto M. Lemoli, Antonio Curti

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche

    Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche por Antonio Giovanni Solimando, Eleonora Malerba, Patrizia Leone, Marcella Prete, Carolina Terragna, Michèle Cavo, Vito Racanelli

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia

    The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia por Marilena Ciciarello, Giulia Corradi, Federica Loscocco, Giuseppe Visani, Federica Monaco, Michèle Cavo, Antonio Curti, Alessandro Isidori

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation

    Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation por Francesca Bonifazi, Francesco Barbato, Federico Ravaioli, Mariarosaria Sessa, Irene Defrancesco, Mario Arpinati, Michèle Cavo, Antonio Colecchia

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling

    The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling por Dorian Forte, Valentina Salvestrini, Giulia Corradi, Lara Rossi, Lucia Catani, Roberto M. Lemoli, Michèle Cavo, Antonio Curti

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients

    Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients por Valentina Salvestrini, Gabriele Conti, Federica D’Amico, Gianluca Cristiano, Marco Candela, Michèle Cavo, Silvia Turroni, Antonio Curti

    Publicado 2025
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.

    Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. por Gösta Gahrton, S Tura, Per Ljungman, Joan Bladé, Lena Brandt, Michèle Cavo, Thierry Façon, Aloïs Gratwohl, Anton Hagenbeek, Peter Jacob

    Publicado 1995
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Proteasome inhibitors in multiple myeloma: 10 years later

    Proteasome inhibitors in multiple myeloma: 10 years later por Philippe Moreau, Paul G. Richardson, Michèle Cavo, Robert Z. Orlowski, Jesús F. San Miguel, Antonio Palumbo, Jean‐Luc Harousseau

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival

    Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell su... por Giulia Corradi, Carmen Baldazzi, Darina Očadlíková, Giovanni Marconi, Sarah Parisi, Nicoletta Testoni, Carlo Finelli, Michèle Cavo, Antonio Curti, Marilena Ciciarello

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

    Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy por Michèle Cavo, Elena Zamagni, Claudia Cellini, Patrizia Tosi, Delia Cangini, Michela Cini, Lelia Valdré, Gualtiero Palareti, Luciano Masini, S Tura, Michele Baccarani

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  16. 16
    Solitary plasmacytoma of bone and extramedullary plasmacytoma: Two different entities?

    Solitary plasmacytoma of bone and extramedullary plasmacytoma: Two different entities? por Piero Galieni, Michèle Cavo, Giuseppe Avvisati, Alessandro Pulsoni, Rosanna Falbo, M. A. Bonelli, Domenico Russo, Maria Teresa Petrucci, Alessandro Bucalossi, S Tura

    Publicado 1995
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies

    A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies por Marta Stanzani, Russell E. Lewis, Mauro Fiacchini, Paolo F. Ricci, Fabio Tumietto, Pierluigi Viale, Simone Ambretti, Michele Baccarani, Michèle Cavo, Nicola Vianelli

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who Were Transplant Ineligible: A Propensity Score Matching Analysis

    Comparison of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) with Standard of Care for Patients from Latin America with Newly Diagnosed Multiple Myeloma (NDMM) Who... por Vânia Hungria, Déborah Martı́nez-Baños, María‐Victoria Mateos, Meletios Α. Dimopoulos, Michèle Cavo, Bart Heeg, Annette Lam, Gerardo Machnicki, Jianming He, Mariana Fernandez

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an &lt;i&gt;ad hoc&lt;/i&gt; expert panel

    Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an &lt;i&gt;ad hoc&lt;/i&gt;... por Valerio De Stefano, Alessandra Larocca, Monica Carpenedo, Michèle Cavo, Francesco Di Raimondo, Anna Falanga, Massimo Offidani, Maria Teresa Petrucci, Marco Ruggeri, Roberto Santi, Giovanni Barosi

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells

    Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+... por Roberto M. Lemoli, Alessandra Fortuna, MR Motta, Simonetta Rizzi, Valentina Giudice, A Nannetti, Giovanni Martinelli, Michèle Cavo, Marilina Amabile, Serena Mangianti, M Fogli, Roberto Conte, S Tura

    Publicado 1996
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: